SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention ahead of topline survival results from its Phase 3 REGAL trial of GPS, after the trial reached its 80th-event milestone; traders are also watching SLS009 data expected at ASH. Many holders are buying or staying invested in anticipation of positive results, while skeptics point to the stocks sharp declines and warn that the trial outcome remains uncertain.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris strong Q3 results, led by rapid Recorlev growth, a higher full-year revenue outlook and a raised 2030 target, have driven a sharp rally and expectations of further analyst upgrades. Traders are broadly bullish on the growth trajectory, while takeover and bidding-war talk remains speculative and unconfirmed.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Discussion centers on a product shown at Foxconns Tech Day and POETs presence in Foxconns photonics ecosystem, which traders view as validation of the optical-engine partnership and a possible step toward commercialization. Bulls are anticipating orders and production updates, while skeptics stress that a demonstration is not proof of purchase orders or scaled shipments.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys engine, technology-licensing and engineering-support agreement with AST SpaceMobile for its planned heavy-lift rocket is driving attention, with traders viewing it as a major validation of Fireflys propulsion business and a boost to its backlog and funding outlook. Some remain cautious about the AST shares included in the deal, potential dilution, execution risks and the upcoming earnings report.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos sharp rebound is being tied to its Q3 update, including a reported earnings beat and an agreement to reserve manufacturing capacity for future reactor components. Traders are split between viewing the supply-chain and nuclear-development progress as a positive signal and arguing that the companys limited revenue, long commercialization timeline, and insider selling and dilution concerns make the bounce fragile.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs stronger-than-expected quarterly results and raised full-year revenue outlook are driving attention, with traders highlighting growth, backlog and momentum across quantum stocks. The reaction is broadly upbeat, though skeptics question cash burn, dilution and how much growth reflects acquisitions rather than the core quantum business.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Anticipation around Netlists Q3 earnings and call is driving attention, with traders watching for guidance and speculating about an SK hynix agreement or Nasdaq uplisting. The Kingston-related ITC complaint is also fueling hopes for further licensing, though some traders caution that broad memory-sector weakness and high expectations could limit the market reaction.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

AMPX is drawing attention after a sharp rebound from a recent selloff, alongside call-heavy options activity and a broader rebound in electrical-equipment and data-center infrastructure stocks. Traders are split on whether the move marks a lasting recovery or a short-term bounce, with the upcoming earnings report also in focus.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

Bitcoins pullback below the mid-$70,000s and heavy spot-ETF outflows are driving attention to IBIT, with traders debating whether the weakness signals further downside or a buying opportunity. Some see support holding and expect a rebound, while others point to redemptions and warn the selloff may continue.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

LUNRs sharp rebound after a steep selloff has traders debating whether short covering and a broader space-sector bounce are driving the move. Some speculate that NASAs upcoming CLPS 2.0 awards or other contract news could provide a catalyst, while others view the rally as temporary; no specific new award is confirmed in the discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VNRX Q2 &#39;26 Earnings Results &amp; Recap

VolitionRx Limited reported total revenues of $0.4 million for the three months ended June 30, 2026, and $1.4 million for the six months ended June 30, 2026, reflecting ongoing commercialization activities.

Eric Jones

Stocktwits

VolitionRX Ltd

 Q2 '26 Earnings Results & Recap

VolitionRx Limited reported total revenues of $0.4 million for the three months ended June 30, 2026, and $1.4 million for the six months ended June 30, 2026, reflecting ongoing commercialization activities.

This account has been verified as an official STOCKTWITS representative.